
What We’re Reading: COVID-19 Vaccine Trial Halted; Virus Spread at Motorcycle Rally; FDA Issues Efficacy Caution
AstraZeneca's phase 3 trial of a coronavirus disease 2019 (COVID-19) vaccine has been temporarily stopped; the Sturgis Motorcycle Rally may have led to over 250,000 COVID-19 cases; a potential treatment for breast cancer may not be effective.
Adverse Event Possible Cause of AstraZeneca COVID-19 Trial Stoppage
Late yesterday, AstraZeneca halted its phase 3 trial in the United States investigating a potential coronavirus disease 2019 (COVID-19) vaccine, pending a safety data review,
Sturgis Motorcycle Rally May Have Led to Superspread of COVID-19 Cases
Researchers from San Diego State University’s Center for Health Economics & Policy Studies claim the annual gathering of motorcycle enthusiasts in Sturgis, South Dakota, may have led to 266,796 cases of COVID-19, according to
Atezolizumab/Paclitaxel Combo Not Effective for Breast Cancer, FDA Says
Results from the Impassion131 phase 3, multicenter, randomized, double-blind, placebo-controlled trial show the combination of atezolizumab (Tecentriq) and paclitaxel was not effective against locally advanced or metastatic triple negative
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.